Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaviscon scintigraphic acid pocket study in GERD
NL-OMON35613Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of magnesium trisilicate in gastroesophageal reflux disease (GERD), sponsored by Amsterdam University Medical Center. Primary endpoint: Acid reflux episodes. Started Jan 2012; status: active, not recruiting.
02
Drugs
magnesium trisilicate
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NL-OMON35613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35613.